TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/8bqskf/transdermal_drug) has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery - Technologies, Markets, and Companies" to their offering.
The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2014 to 2024
This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.
The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described.
Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease.
Benefits of this report:
- Up-to-date one-stop information on transdermal drug delivery
- Description of 109 companies involved and 110 collaborations in this area
- Market analysis 2014-2024
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 220 publications
- Text is supplemented by 22 tables and 13 figures
Key Topics Covered:
Executive Summary
1. Basics of Transdermal Drug Delivery
2. Transdermal Drug Delivery Technologies
3. Transdermal Therapeutics
4. Markets for Transdermal Drug Delivery
5. Companies involved in transdermal drug delivery
6. References
For more information visit http://www.researchandmarkets.com/research/8bqskf/transdermal_drug
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery
